These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2652554)

  • 1. Factors influencing the improvement in cadaveric renal transplant survival in pediatric recipients.
    Ettenger RB; Rosenthal JT; Marik J; Forsythe S; Malekzadeh MH; Kamil E; Salusky IB; Fine RN
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1693-5. PubMed ID: 2652554
    [No Abstract]   [Full Text] [Related]  

  • 2. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful cadaveric renal transplantation in infants and young children.
    Ettenger RB; Rosenthal JT; Marik J; Salusky IB; Kamil E; Malekzadeh MH; Fine RN
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1707-8. PubMed ID: 2652559
    [No Abstract]   [Full Text] [Related]  

  • 4. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract]   [Full Text] [Related]  

  • 5. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
    Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in donor-specific cell-mediated lympholysis (CML) response associated with success of early steroid withdrawal in DST-azathioprine-treated renal transplant recipients.
    Burlingham WJ; Grailer A; Sollinger HW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1818-9. PubMed ID: 2523595
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation of cadaver kidneys from pediatric and older donors.
    Bow L; Roper L; Bartus S; Hull D; Schweizer RT
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1938-9. PubMed ID: 2652632
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 9. A flexible immunosuppression protocol for organ transplantation using cyclosporine, azathioprine, and prednisone.
    Schweizer RT; Rovelli M; Roper L; Bartus SA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1944-6. PubMed ID: 3079062
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum beta 2 microglobulin monitoring in cadaver kidney transplant recipients with oliguric renal failure.
    Schweizer RT; Roper L; Hull D; Bartus S
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1867-8. PubMed ID: 2652607
    [No Abstract]   [Full Text] [Related]  

  • 11. Is cyclosporine indicated in HLA-identical renal transplant recipients?
    Sumrani N; Delaney V; Ding Z; Davis R; Butt K; Hong J
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1239-40. PubMed ID: 1989199
    [No Abstract]   [Full Text] [Related]  

  • 12. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
    Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal transplantation in children using cyclosporin A and azathioprine.
    Clark AG; Rigden SP; Welsh KI; Bewick M; Koffman G; Haycock GB; Chantler C
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1685-6. PubMed ID: 2652552
    [No Abstract]   [Full Text] [Related]  

  • 15. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
    Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric cadaveric kidneys in recipients treated with cyclosporine.
    Smith AY; Kerman RH; Van Buren CT; Lewis RM; Kahan BD
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):215-21. PubMed ID: 3291246
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.
    Restifo AC; Petrie JJ; Rigby RJ; Hardie IR; Jacob CK; Russ GR; Mathew TH
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1604-5. PubMed ID: 2652522
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine (Cy) monotherapy after cadaveric renal transplantation.
    Margreiter R; Bösmüller C; Spielberger M; Schmid T; Königsrainer A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1591-3. PubMed ID: 2652518
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial of azathioprine in combination with cyclosporine in cadaveric renal transplantation.
    Griffin PJ; Ferguson CJ; Ross WB; Salaman JR
    Transplant Proc; 1990 Aug; 22(4):1369. PubMed ID: 2202112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.